In 2024 several ASX medtech companies have upcoming catalysts as they strive to innovate healthcare Primary results of EBR’s SOLVE trial expected to be published in a leading peer reviewed journal in...
Source LinkIn 2024 several ASX medtech companies have upcoming catalysts as they strive to innovate healthcare Primary results of EBR’s SOLVE trial expected to be published in a leading peer reviewed journal in...
Source Link
Comments